Back
Seres Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
MCRB
Seres Therapeutics, Inc.
Last Price:
$15.10
Seasonality Move:
-13.23%
7 Day Trial
ALL ACCESS PASS
$
7
Seres Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Seres Therapeutics, Inc. has on average historically risen by 27.9% based on the past 10 years of stock performance.
-
Seres Therapeutics, Inc. has risen higher in 1 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 10%
-
Is Seres Therapeutics, Inc. Stock Undervalued?The current Seres Therapeutics, Inc. [MCRB] share price is $15.96. The Score for MCRB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
MCRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Seres Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Seres Therapeutics, Inc. has on average historically risen by 27.9% based on the past 10 years of stock performance.
Seres Therapeutics, Inc. Stock Rating
Sell
27
Seres Therapeutics, Inc. (MCRB)
is a Sell
Is Seres Therapeutics, Inc. overpriced?
-
Seres Therapeutics, Inc. has risen higher in 1 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 10%
Seres Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
serestherapeutics.com
52-Week Data
52-Week High:
29.98
52-Week Low:
6.53
Prediction Charts
Market Cap:
139.7M
Price in USD:
15.96
Volume:
46K
Beta:
2.08
Technical Analysis
SMA50:
16.51
SMA100:
17.52
SMA200:
14.20
52-Wk Change:
8.57%
Stock Predictions
-
Is Seres Therapeutics, Inc. stock public?Yes, Seres Therapeutics, Inc. is a publicly traded company.
-
What is the Seres Therapeutics, Inc. stock quote today?The Seres Therapeutics, Inc. stock price is 15.96 USD today.
-
How to buy Seres Therapeutics, Inc. stock online?You can buy Seres Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-29 | 14.63 | 14.92 | 15.15 | 14.01 |
| Dec-30 | 15.00 | 14.44 | 15.00 | 14.35 |
| Dec-31 | 14.65 | 14.88 | 15.09 | 14.65 |
| Jan-5 | 15.30 | 15.19 | 15.39 | 14.50 |
| Jan-6 | 15.01 | 15.55 | 16.03 | 15.01 |
| Jan-7 | 15.46 | 15.86 | 16.30 | 15.46 |
| Jan-8 | 16.05 | 15.45 | 16.05 | 15.11 |
| Jan-9 | 15.43 | 15.65 | 15.68 | 15.03 |
| Jan-12 | 15.50 | 15.84 | 16.00 | 14.90 |
| Jan-13 | 15.75 | 15.97 | 15.97 | 15.03 |
| Jan-14 | 16.00 | 16.08 | 16.42 | 15.75 |
| Jan-15 | 16.00 | 15.18 | 16.27 | 15.00 |
| Jan-16 | 15.13 | 15.96 | 16.05 | 15.07 |
| Jan-20 | 15.60 | 15.06 | 15.60 | 15.00 |
Seres Therapeutics, Inc. Earnings
Seres Therapeutics, Inc. Earnings Report: Per Share Seres Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Seres Therapeutics, Inc. Forecast Revenue Growth
Seres Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Seres Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, a decrease this year of $11.20 per share, and a decrease next year of $1.03 per share.
* Seres Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.